BioDrugs (2024 IF 6.9) covers the development and therapeutic application of biotechnology-based pharmaceuticals for the treatment of human disease.

New Zealand
Joined March 2010
BioDrugs Journal retweeted
Online today this state of the art review in @BioDrugsJournal led by @wyatt_nic comprehensively summarising the literature around licensed and emerging treatments targeting leukocyte trafficking (integrins, S1P and MAdCAM-1) in #IBD. Free download here! rdcu.be/cy3oW
7
1
19
BioDrugs Journal retweeted
Celebrating #50YearsofDrugs in 2021. Delightful Editorial by Sir Graeme Avery, the founding publisher and first editor now online '50 Years on Still Relevant' bit.ly/3oMD07s
1
10
3
5